Last reviewed · How we verify
LANTHANUM CARBONATE
LANTHANUM CARBONATE is a drug. It is currently FDA-approved (first approved 2004).
At a glance
| Generic name | LANTHANUM CARBONATE |
|---|---|
| Modality | Small molecule |
| Phase | FDA-approved |
| First approval | 2004 |
Approved indications
Common side effects
- Nausea
- Vomiting
- Abdominal pain
- Diarrhea
- Hypocalcemia
Serious adverse events
- Intestinal perforation
- Intestinal obstruction
- Ileus
- Subileus
- Constipation
- Hypophosphatemia
- Allergic skin reactions
- Dyspepsia
- Tooth injury while chewing tablet
Key clinical trials
- Drug-drug Interaction Study of TPOXX When Co-administered With Phosphate Binders (PHASE4)
- Healthy Combine Study (PHASE1)
- The Effect of Lanthanum Carbonate on Fibroblast Growth Factor 23 ( FGF23) in Chronic Kidney Disease (NA)
- Phosphate Lowering in CKD Trial (PHASE4)
- The COMBINE Study: The CKD Optimal Management With BInders and NicotinamidE (PHASE2)
- To Evaluate the Patient Tolerance, Pharmacodynamics and Pharmacokinetics of Lanthanum Polystyrene Sulfonate Powder (PHASE1, PHASE2)
- Different Effects of Non-calcium Phosphate Binders on Serum Calcium (PHASE4)
- Long-term Effect of Lanthanum Carbonate on Bone
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- LANTHANUM CARBONATE CI brief — competitive landscape report
- LANTHANUM CARBONATE updates RSS · CI watch RSS
Frequently asked questions about LANTHANUM CARBONATE
What is LANTHANUM CARBONATE?
LANTHANUM CARBONATE is a Small molecule drug.
When was LANTHANUM CARBONATE approved?
LANTHANUM CARBONATE was first approved on 2004.
What development phase is LANTHANUM CARBONATE in?
LANTHANUM CARBONATE is FDA-approved (marketed).
What are the side effects of LANTHANUM CARBONATE?
Common side effects of LANTHANUM CARBONATE include Nausea, Vomiting, Abdominal pain, Diarrhea, Hypocalcemia. Serious adverse events: Intestinal perforation, Intestinal obstruction, Ileus, Subileus.
Related
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing